STOCK TITAN
  1. Home
  2. Sec-filings
  3. INM
  4. [Form 3] InMed Pharmaceuticals Inc. Initial Statement of Beneficial Ownership

InMed (INM) major holder ADAR1 reports 331,449 indirect shares on Form 3

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
3

Rhea-AI Filing Summary

InMed Pharmaceuticals Inc. filed an initial ownership report showing that private investment funds managed by ADAR1 Capital Management, LLC hold 331,449 Common Shares of InMed. These shares may be deemed indirectly beneficially owned by ADAR1 and by Daniel Schneeberger, its sole manager, through their interests in the funds.

Both ADAR1 and Schneeberger are listed as ten percent owners. The filing states that each reporting person disclaims beneficial ownership of these securities except to the extent of any pecuniary interest.

Positive

  • None.

Negative

  • None.
Insider ADAR1 Capital Management, LLC, Schneeberger Daniel
Role null | null
Type Security Shares Price Value
holding Common Shares -- -- --
Holdings After Transaction: Common Shares — 331,449 shares (Indirect, See Footnote)
Footnotes (1)
  1. The reported securities are owned directly by private investment funds managed by ADAR1 Capital Management, LLC, and may be deemed to be indirectly beneficially owned by (i) ADAR1 Capital Management, LLC and (ii) Daniel Schneeberger, the sole manager of ADAR1 Capital Management, LLC. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise.
Indirect Common Shares Held 331,449 shares Common Shares indirectly owned through funds managed by ADAR1 as of 2026-05-19
indirectly beneficially owned financial
"may be deemed to be indirectly beneficially owned by (i) ADAR1 Capital Management, LLC and (ii) Daniel Schneeberger"
pecuniary interest financial
"disclaims beneficial ownership of any such securities, except to the extent of his/its pecuniary interest therein"
Section 16 of the Securities Exchange Act of 1934 regulatory
"For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership"
A provision of federal securities law that requires company insiders—directors, officers and large shareholders—to publicly report their stock holdings and trades and to surrender any “short-swing” profits from purchases and sales within a six-month window. It acts like a rule that forces leaders to announce their trades and prevents quick buy-sell windfalls, giving investors transparency into insider activity and reducing opportunities for unfair gain.
ten percent owner financial
"each Reporting Person is listed as a ten percent owner"
Understanding Insider Trading Forms →
SEC Form 3
FORM 3UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0104
Estimated average burden
hours per response:0.5
1. Name and Address of Reporting Person*
ADAR1 Capital Management, LLC
(Last)(First)(Middle)
3503 WILD CHERRY DRIVE
BUILDING 9
(Street)
AUSTIN TEXAS 78738
(City)(State)(Zip)
UNITED STATES
(Country)		2. Date of Event Requiring Statement (Month/Day/Year)
05/19/2026		3. Issuer Name and Ticker or Trading Symbol
InMed Pharmaceuticals Inc. [ INM ]
3a. Foreign Trading Symbol
5. If Amendment, Date of Original Filed (Month/Day/Year)
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
DirectorX10% Owner
Officer (give title below)Other (specify below)
6. Individual or Joint/Group Filing (Check Applicable Line)
Form filed by One Reporting Person
XForm filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Shares331,449ISee Footnote(1)(2)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year)3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
1. Name and Address of Reporting Person*
ADAR1 Capital Management, LLC
(Last)(First)(Middle)
3503 WILD CHERRY DRIVE
BUILDING 9
(Street)
AUSTIN TEXAS 78738
(City)(State)(Zip)
UNITED STATES
(Country)
Relationship of Reporting Person(s) to Issuer
DirectorX10% Owner
Officer (give title below)Other (specify below)
1. Name and Address of Reporting Person*
Schneeberger Daniel
(Last)(First)(Middle)
3503 WILD CHERRY DRIVE, BUILDING 9
(Street)
AUSTIN TEXAS 78738
(City)(State)(Zip)
UNITED STATES
(Country)
Relationship of Reporting Person(s) to Issuer
DirectorX10% Owner
Officer (give title below)Other (specify below)
Explanation of Responses:
1. The reported securities are owned directly by private investment funds managed by ADAR1 Capital Management, LLC, and may be deemed to be indirectly beneficially owned by (i) ADAR1 Capital Management, LLC and (ii) Daniel Schneeberger, the sole manager of ADAR1 Capital Management, LLC.
2. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise.
ADAR1 Capital Management, LLC By: Daniel Schneeberger, Manager /s/ Daniel Schneeberger05/21/2026
/s/ Daniel Schneeberger05/21/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider position does the Form 3 report for InMed Pharmaceuticals (INM)?

The Form 3 reports that private investment funds managed by ADAR1 Capital Management, LLC hold 331,449 Common Shares of InMed Pharmaceuticals. ADAR1 and its sole manager, Daniel Schneeberger, are listed as ten percent owners based on these indirect holdings.

Who are the reporting persons on this InMed (INM) Form 3 filing?

The reporting persons are ADAR1 Capital Management, LLC and Daniel Schneeberger. Schneeberger is identified as the sole manager of ADAR1, and both are reported as ten percent owners due to indirect holdings in private investment funds owning InMed shares.

How many InMed (INM) shares are reported as indirectly owned in this Form 3?

The filing shows 331,449 Common Shares of InMed Pharmaceuticals indirectly owned through private investment funds managed by ADAR1 Capital Management, LLC. This total reflects the position after the reported holding entry as of the transaction date in the document.

Does ADAR1 Capital Management claim full beneficial ownership of InMed (INM) shares?

No. The filing states each reporting person disclaims beneficial ownership of the reported InMed securities, except to the extent of his or its pecuniary interest. This means they only acknowledge economic interest in the shares to the extent they benefit financially.

Are the InMed (INM) shares on this Form 3 held directly or indirectly?

The 331,449 Common Shares are held indirectly through private investment funds. The filing classifies the ownership as indirect and notes that ADAR1 Capital Management, LLC manages these funds, with Daniel Schneeberger as its sole manager.